Lead discovery: Tailoring nuclear receptor activation

P. Kirkpatrick

DOI: https://doi.org/10.1038/nrd2807

2009-01-23

Abstract:

What problem does this paper attempt to address?

Physiologically informed neuromodulation

Karen Wendt,Timothy Denison,Gaynor Foster,Lothar Krinke,Alix Thomson,Saydra Wilson,Alik S Widge

DOI: https://doi.org/10.1016/j.jns.2021.120121

2022-03-15

Abstract:The rapid evolution of neuromodulation techniques includes an increasing amount of research into stimulation paradigms that are guided by patients' neurophysiology, to increase efficacy and responder rates. Treatment personalisation and target engagement have shown to be effective in fields such as Parkinson's disease, and closed-loop paradigms have been successfully implemented in cardiac defibrillators. Promising avenues are being explored for physiologically informed neuromodulation in psychiatry. Matching the stimulation frequency to individual brain rhythms has shown some promise in transcranial magnetic stimulation (TMS). Matching the phase of those rhythms may further enhance neuroplasticity, for instance when combining TMS with electroencephalographic (EEG) recordings. Resting-state EEG and event-related potentials may be useful to demonstrate connectivity between stimulation sites and connected areas. These techniques are available today to the psychiatrist to diagnose underlying sleep disorders, epilepsy, or lesions as contributing factors to the cause of depression. These technologies may also be useful in assessing the patient's brain network status prior to deciding on treatment options. Ongoing research using invasive recordings may allow for future identification of mood biomarkers and network structure. A core limitation is that biomarker research may currently be limited by the internal heterogeneity of psychiatric disorders according to the current DSM-based classifications. New approaches are being developed and may soon be validated. Finally, care must be taken when incorporating closed-loop capabilities into neuromodulation systems, by ensuring the safe operation of the system and understanding the physiological dynamics. Neurophysiological tools are rapidly evolving and will likely define the next generation of neuromodulation therapies.
Precoding and Power Allocation for Full-Duplex MIMO Relays

Jong-Ho Lee,Oh-Soon Shin

DOI: https://doi.org/10.1587/TRANSCOM.E94.B.2316

2011-08-01

IEICE Transactions on Communications

Abstract:
Reversible and Noninvasive Modulation of a Historical Surgical Target for Depression with Low Intensity Focused Ultrasound

Aki Tsuchiyagaito,Rayus Kuplicki,Masaya Misaki,Landon S Edwards,Joan A Camprodon,Kate D Fitzgerald,Sahib S Khalsa,Noah S Philip,Martin P Paulus,Salvador M Guinjoan

DOI: https://doi.org/10.1101/2024.09.30.24314619

2024-10-01

Abstract:Major depressive disorder has a point prevalence of 5% of the world population and is the main cause of disability, with up to a third of patients not responding to first-line treatments. Surgical neuromodulation is offered to only an anecdotal proportion of these patients, because while these methods are curative in some individuals, the proportion of responders rarely exceeds 50%. Recent efforts to establish reliable brain circuit-symptom relationships and thus predict response have involved mapping with multiple intracranial electrodes, but the impracticality of this approach currently prevents its application at scale. In the present study (ClinicalTrials.gov identifier ; FDA Q220192) we begin to address this gap by leveraging low-intensity focused ultrasound (LIFU), a novel noninvasive technique, to modulate the anterior limb of the internal capsule, which is an established surgical deep white matter target for depression. We based our study on burgeoning in vitro evidence that LIFU attenuates axonal conduction by operating mechanosensitive channels in nodes of Ranvier. Compared with sham stimulus, active LIFU produced a functional disconnection of gray matter hubs reached by the sonicated axonal tracts, an increase in positive emotion, and top-down effects on the cardiovascular autonomic balance. Our results using LIFU of deep-brain white matter tracts in humans open three potential avenues to understand the mechanisms and improve the outcome of depression, namely attaining a personalized definition of brain circuit-symptom relationships, serving as a noninvasive probe for neuromodulation before irreversible procedures in a "try before you buy" approach, and ultimately emerging as a therapeutic intervention itself.

Psychiatry and Clinical Psychology
Brain-Computer Interface Based Neuromodulation on Treatment of Depression

Yijiang Li

DOI: https://doi.org/10.54097/sfx0ya89

2023-12-29

Abstract:Major Depressive Disorder (MDD) represents a significant societal burden, with traditional first-line treatments often falling short. This pressing issue has spurred the exploration of neuromodulation therapies, demonstrating superior efficacy compared to conventional pharmaceutical interventions. The present review provides a rigorous evaluation of four advanced neuromodulation techniques: Focal Electrically Administered Seizure Therapy (FEAST), Transcranial Magnetic Stimulation (TMS), Intermittent Theta-Burst Stimulation (iTBS), and Magnetic Seizure Therapy (MST). A comprehensive analytical comparison is offered, focusing on their efficacy, feasibility, economic considerations, and underlying mechanisms. Among these therapies, iTBS, integrated with Brain-Computer Interface (BCI) systems, has emerged as notably effective, with clinical trials indicating an average 80% efficacy at a reduced economic cost. FEAST and MST, supported by recent research, also exhibit strong efficacy, around 60%, although with more pronounced side effects. TMS, in contrast, exhibits a slightly reduced efficacy but is promising due to its minimal side effects. The review further delves into the transformative role of increasingly sophisticated BCI technologies in addressing previously identified challenges of neuromodulation therapy, such as adverse side effects, time-consuming procedures, and high costs. These technological advancements are elucidated, emphasizing their contribution to more precise therapy delivery and an enhanced patient experience. The review culminates in illuminating a pathway for the harmonious integration of neuromodulation therapies with traditional psychopharmacological treatments, positioning this integrative approach as a groundbreaking paradigm poised to redefine the landscape of depression treatment.
Non-Invasive Electric and Magnetic Brain Stimulation for the Treatment of Fibromyalgia

Andrés Molero-Chamizo,Michael A. Nitsche,Rafael Tomás Andújar Barroso,José R. Alameda Bailén,Jesús Carlos García Palomeque,Guadalupe Nathzidy Rivera-Urbina

DOI: https://doi.org/10.3390/biomedicines11030954

IF: 4.757

2023-03-21

Biomedicines

Abstract:Although fibromyalgia is defined by its core muscular nociceptive component, it also includes multiple dysfunctions that involve the musculoskeletal, gastrointestinal, immune, endocrine, as well as the central and peripheral nervous systems, amongst others. The pathogenic involvement of the nervous system and the numerous neurological and neuroinflammatory symptoms of this disease may benefit from neuromodulatory stimulation techniques that have been shown to be effective and safe in diverse nervous system pathologies. In this systematic review, we outline current evidence showing the potential of non-invasive brain stimulation techniques, such as therapeutic strategies in fibromyalgia. In addition, we evaluate the contribution of these tools to the exploration of the neurophysiological characteristics of fibromyalgia. Considering that the pathogenesis of this disease is unknown, these approaches do not aim to causally treat this syndrome, but to significantly reduce a range of key symptoms and thus improve the quality of life of the patients.

biochemistry & molecular biology,medicine, research & experimental,pharmacology & pharmacy
Zygomaticus activation through facial neuromuscular electric stimulation (fNMES) induces happiness perception in ambiguous facial expressions and affects neural correlates of face processing

Themis Nikolas Efthimiou,Joshua Baker,Alasdair Clarke,Arthur Elsenaar,Marc Mehu,Sebastian Korb

DOI: https://doi.org/10.1093/scan/nsae013

IF: 4.235

2024-02-11

Social Cognitive and Affective Neuroscience

Abstract:The role of facial feedback in facial emotion recognition remains controversial, partly due to limitations of the existing methods to manipulate the activation of facial muscles, such as voluntary posing of facial expressions, or holding a pen in the mouth. These procedures are indeed limited in their control over which muscles are (de)activated when and to what degree. To overcome these limitations and investigate in a more controlled way if facial emotion recognition is modulated by one's facial muscle activity, we used computer-controlled facial neuromuscular electrical stimulation (fNMES). In a pre-registered EEG experiment, ambiguous facial expressions were categorised as happy or sad by 47 participants. In half of the trials, weak smiling was induced through fNMES delivered to the bilateral Zygomaticus Major muscle for 500 ms. The likelihood of categorising ambiguous facial expressions as happy was significantly increased with fNMES, as shown with frequentist and Bayesian linear mixed models. Further, fNMES resulted in a reduction of P1, N170 and LPP amplitudes. These findings suggest that fNMES-induced facial feedback can bias facial emotion recognition and modulate the neural correlates of face processing. We conclude that fNMES has potential as a tool for studying the effects of facial feedback.

psychology, experimental,neurosciences
Brief Myofascial Intervention Modulates Visual Event-Related Potential Response to Emotional Photographic Contents: A Pilot Study

Gabriel Byczynski,Amedeo D'Angiulli

DOI: https://doi.org/10.3390/vision7040077

2023-12-13

Abstract:The use of touch for the treatment of psychiatric disorders is increasingly investigated, as it is shown that cognitive symptoms can be improved by various forms of massage. To investigate if the effect of massage is measurable using classical visual event-related potential components (P1, P2, late positive potential (LPP)), we performed a preliminary study on six participants using myofascial induction massage. Participants were shown emotionally valenced or neutral images before and after a 20 min myofascial massage. We found general increases in P2 amplitude following the intervention across all conditions (both neutral and affective), indicating increased attention or salience to visual stimuli. The magnitude of change was visibly larger for unpleasant stimuli, suggesting that visual perception and attention were modulated specifically in response to unpleasant visual images. The LPP showed reductions in amplitude after myofascial massage, suggesting increased emotional modulation following intervention, as a result of possible DMN alterations, consistent with region and function. We conclude that brief myofascial intervention supports other research in the field, finding that physical touch and massage techniques can alter cognition and perception. We posit further research to investigate its future use as an intervention for both physical and cognitive modulation. Importantly, we provide preliminary evidence that the neural processes that resonate with this type of massage involve complex feedforward and backward cortical pathways, of which a significant portion participate in modulating the visual perception of external stimuli.
Epidemiological aspects of vector, parasite, and domestic reservoir in areas of recent transmission and no reported human cases of visceral leishmaniasis in Brazil.

F. O. Lara-Silva,E. .Michalsky,C. L. Fortes-Dias,V. O. Fiúza,J. E. Pessanha,Shara Regina-Silva,D. M. de Avelar,M. A. Silva,A. C. V. Lima,A. J. A. da Costa,G. Machado-Coelho,E. Dias

DOI: https://doi.org/10.1016/j.actatropica.2015.04.002

IF: 3.222

2015-08-01

Acta Tropica

Abstract:
Emotion self-regulation training in major depressive disorder using simultaneous real-time fMRI and EEG neurofeedback

Vadim Zotev,Ahmad Mayeli,Masaya Misaki,Jerzy Bodurka

DOI: https://doi.org/10.1016/j.nicl.2020.102331

2020-01-01

Abstract:Simultaneous real-time fMRI and EEG neurofeedback (rtfMRI-EEG-nf) is an emerging neuromodulation approach, that enables simultaneous volitional regulation of both hemodynamic (BOLD fMRI) and electrophysiological (EEG) brain activities. Here we report the first application of rtfMRI-EEG-nf for emotion self-regulation training in patients with major depressive disorder (MDD). In this proof-of-concept study, MDD patients in the experimental group (n=16) used rtfMRI-EEG-nf during a happy emotion induction task to simultaneously upregulate two fMRI and two EEG activity measures relevant to MDD. The target measures included BOLD activities of the left amygdala (LA) and left rostral anterior cingulate cortex (rACC), and frontal EEG asymmetries in the alpha band (FAA, [7.5-12.5] Hz) and high-beta band (FBA, [21-30] Hz). MDD patients in the control group (n=8) were provided with sham feedback signals. An advanced procedure for improved real-time EEG-fMRI artifact correction was implemented. The experimental group participants demonstrated significant upregulation of the LA BOLD activity, FAA, and FBA during the rtfMRI-EEG-nf task, as well as significant enhancement in fMRI connectivity between the LA and left rACC. Average individual FAA changes during the rtfMRI-EEG-nf task positively correlated with depression and anhedonia severities, and negatively correlated with after-vs-before changes in depressed mood ratings. Temporal correlations between the FAA and FBA time courses and the LA BOLD activity were significantly enhanced during the rtfMRI-EEG-nf task. The experimental group participants reported significant mood improvements after the training. Our results suggest that the rtfMRI-EEG-nf may have potential for treatment of MDD.
Neural responses to facial emotions and subsequent clinical outcomes in difficult-to-treat depression

Diede Fennema,Gareth J. Barker,Owen O'Daly,Suqian Duan,Beata R. Godlewska,Kimberley Goldsmith,Allan H. Young,Jorge Moll,Roland Zahn

DOI: https://doi.org/10.1017/s0033291724001144

IF: 10.592

2024-05-19

Psychological Medicine

Abstract:Background Amygdala and dorsal anterior cingulate cortex responses to facial emotions have shown promise in predicting treatment response in medication-free major depressive disorder (MDD). Here, we examined their role in the pathophysiology of clinical outcomes in more chronic, difficult-to-treat forms of MDD. Methods Forty-five people with current MDD who had not responded to ⩾2 serotonergic antidepressants (n = 42, meeting pre-defined fMRI minimum quality thresholds) were enrolled and followed up over four months of standard primary care. Prior to medication review, subliminal facial emotion fMRI was used to extract blood-oxygen level-dependent effects for sad v. happy faces from two pre-registered a priori defined regions: bilateral amygdala and dorsal/pregenual anterior cingulate cortex. Clinical outcome was the percentage change on the self-reported Quick Inventory of Depressive Symptomatology (16-item). Results We corroborated our pre-registered hypothesis (NCT04342299) that lower bilateral amygdala activation for sad v. happy faces predicted favorable clinical outcomes (r s [38] = 0.40, p = 0.01). In contrast, there was no effect for dorsal/pregenual anterior cingulate cortex activation (r s [38] = 0.18, p = 0.29), nor when using voxel-based whole-brain analyses (voxel-based Family-Wise Error-corrected p < 0.05). Predictive effects were mainly driven by the right amygdala whose response to happy faces was reduced in patients with higher anxiety levels. Conclusions We confirmed the prediction that a lower amygdala response to negative v. positive facial expressions might be an adaptive neural signature, which predicts subsequent symptom improvement also in difficult-to-treat MDD. Anxiety reduced adaptive amygdala responses.

psychiatry,psychology, clinical
Facing emotions: real-time fMRI-based neurofeedback using dynamic emotional faces to modulate amygdala activity

Apurva Watve,Amelie Haugg,Nada Frei,Yury Koush,David Willinger,Annette Beatrix Bruehl,Philipp Stämpfli,Frank Scharnowski,Ronald Sladky

DOI: https://doi.org/10.3389/fnins.2023.1286665

IF: 4.3

2024-01-12

Frontiers in Neuroscience

Abstract:Introduction: Maladaptive functioning of the amygdala has been associated with impaired emotion regulation in affective disorders. Recent advances in real-time fMRI neurofeedback have successfully demonstrated the modulation of amygdala activity in healthy and psychiatric populations. In contrast to an abstract feedback representation applied in standard neurofeedback designs, we proposed a novel neurofeedback paradigm using naturalistic stimuli like human emotional faces as the feedback display where change in the facial expression intensity (from neutral to happy or from fearful to neutral) was coupled with the participant's ongoing bilateral amygdala activity. Methods: The feasibility of this experimental approach was tested on 64 healthy participants who completed a single training session with four neurofeedback runs. Participants were assigned to one of the four experimental groups ( n = 16 per group), i.e., happy-up, happy-down, fear-up, fear-down. Depending on the group assignment, they were either instructed to "try to make the face happier" by upregulating (happy-up) or downregulating (happy-down) the amygdala or to "try to make the face less fearful" by upregulating (fear-up) or downregulating (fear-down) the amygdala feedback signal. Results: Linear mixed effect analyses revealed significant amygdala activity changes in the fear condition, specifically in the fear-down group with significant amygdala downregulation in the last two neurofeedback runs as compared to the first run. The happy-up and happy-down groups did not show significant amygdala activity changes over four runs. We did not observe significant improvement in the questionnaire scores and subsequent behavior. Furthermore, task-dependent effective connectivity changes between the amygdala, fusiform face area (FFA), and the medial orbitofrontal cortex (mOFC) were examined using dynamic causal modeling. The effective connectivity between FFA and the amygdala was significantly increased in the happy-up group (facilitatory effect) and decreased in the fear-down group. Notably, the amygdala was downregulated through an inhibitory mechanism mediated by mOFC during the first training run. Discussion: In this feasibility study, we intended to address key neurofeedback processes like naturalistic facial stimuli, participant engagement in the task, bidirectional regulation, task congruence, and their influence on learning success. It demonstrated that such a versatile emotional face feedback paradigm can be tailored to target biased emotion processing in affective disorders.

neurosciences
Brain stimulation over the left DLPFC enhances motivation for effortful rewards in patients with major depressive disorder

Rong Bi,Yanli Zhao,Sijin Li,Feng Xu,Weiwei Peng,Shuping Tan,Dandan Zhang

DOI: https://doi.org/10.1016/j.jad.2024.04.064

IF: 6.533

2024-04-20

Journal of Affective Disorders

Abstract:Background Amotivation is a typical feature in major depressive disorder (MDD), which produces reduced willingness to exert effort. The dorsolateral prefrontal cortex (DLPFC) is a crucial structure in goal-directed actions and therefore is a potential target in modulating effortful motivation. However, it remains unclear whether the intervention is effective for patients with MDD. Methods We employed transcranial magnetic stimulation (TMS), computational modelling and event-related potentials (ERPs) to reveal the causal relationship between the left DLPFC and motivation for effortful rewards in MDD. Fifty patients underwent both active and sham TMS sessions, each followed by performing an Effort-Expenditure for Rewards Task, during which participants chose and implemented between low-effort/low-reward and high-effort/high-reward options. Results The patients showed increased willingness to exert effort for rewards during the DLPFC facilitated session, compared with the sham session. They also had a trend in larger P3 amplitude for motivated attention toward chosen options, larger CNV during preparing for effort exertion, and larger SPN during anticipating a high reward. Besides, while behavior indexes for effortful choices were negatively related to depression severity in the sham session, this correlation was weakened in the active stimulation session. Conclusions These findings provide behavioral, computational, and neural evidence for the left DLPFC on effortful motivation for rewards. Facilitated DLPFC improves motor preparation and value anticipation after making decisions especially for highly effortful rewards in MDD. Facilitated DLPFC also has a potential function in enhancing motivated attention during cost-benefit trade-off. This neuromodulation effect provides a potential treatment for improving motivation in clinics.

psychiatry,clinical neurology
Thermo-mechanical analysis of MEMS pressure sensor die-attach for high temperature applications

K. Meyyappan,P. McCluskey,Liangyu Chen

DOI: https://doi.org/10.1109/AERO.2004.1368049

2004-03-13

Abstract:The thermomechanical stress generated by the mismatch of the coefficients of thermal expansion (CTE) of the sensor base material (SiC) and the packaging has a significant impact on the reliability of the packaged sensor. In the current work, non-linear finite element analysis was performed to determine the peeling, shear stresses and the von Mises stresses, in the SiC pressure sensor and the die attach which is intended for high temperature operation. A parametric study has been conducted to study the effects of the substrate material and reference (stress-free) temperature.
Major depressive disorder associated alterations in the effective connectivity of the face processing network: a systematic review

Alec J. Jamieson,Christine A. Leonards,Christopher G. Davey,Ben J. Harrison

DOI: https://doi.org/10.1038/s41398-024-02734-0

2024-01-26

Translational Psychiatry

Abstract:Major depressive disorder (MDD) is marked by altered processing of emotional stimuli, including facial expressions. Recent neuroimaging research has attempted to investigate how these stimuli alter the directional interactions between brain regions in those with MDD; however, methodological heterogeneity has made identifying consistent effects difficult. To address this, we systematically examined studies investigating MDD-associated differences present in effective connectivity during the processing of emotional facial expressions. We searched five databases: PsycINFO, EMBASE, PubMed, Scopus, and Web of Science, using a preregistered protocol (registration number: CRD42021271586). Of the 510 unique studies screened, 17 met our inclusion criteria. These studies identified that compared with healthy controls, participants with MDD demonstrated (1) reduced connectivity from the dorsolateral prefrontal cortex to the amygdala during the processing of negatively valenced expressions, and (2) increased inhibitory connectivity from the ventromedial prefrontal cortex to amygdala during the processing of happy facial expressions. Most studies investigating the amygdala and anterior cingulate cortex noted differences in their connectivity; however, the precise nature of these differences was inconsistent between studies. As such, commonalities observed across neuroimaging modalities warrant careful investigation to determine the specificity of these effects to particular subregions and emotional expressions. Future research examining longitudinal connectivity changes associated with treatment response may provide important insights into mechanisms underpinning therapeutic interventions, thus enabling more targeted treatment strategies.

psychiatry
Evaluation of a Novel Therapeutic Repetitive Transcranial Magnetic Stimulation Technique Optimized for Increased Accessibility in Major Depression

Jean-Philippe Miron,Helena Voetterl,Linsay Fox,Molly Hyde,Farrokh Mansouri,Sinjin Dees,Ryan Zhou,Jack Sheen,Arsalan Mir-Moghtadaei,Daniel M. Blumberger,Zafiris J. Daskalakis,Fidel Vila-Rodriguez,Jonathan Downar

DOI: https://doi.org/10.1101/2020.06.15.20132092

2020-06-17

Abstract:ABSTRACT BACKGROUND Repetitive transcranial magnetic stimulation (rTMS) is effective in major depressive disorder (MDD). However, technical complexity and operational costs might have been barriers for its wide use and implementation in some jurisdictions, thereby decreasing accessibility. OBJECTIVE Our main goal was to test the feasibility of a novel rTMS protocol optimized for practicality, scalability and cost-effectiveness. We hypothesized that our novel rTMS protocol would be simple to implement and well-tolerated, but less costly and allow for more treatment capacity. METHODS Treatment was administered in an open-room setting, allowing a single technician to attend to multiple patients. Large non-focal parabolic coils held by custom-built arms allowed simple yet efficient and accurate placement. We employed a low-frequency (LF) 1 Hz stimulation protocol (360 pulses per session), delivered on the most affordable FDA-approved devices. MDD participants received an initial accelerated rTMS course (arTMS) of 6 sessions/day over 5 days (30 total), followed by a tapering course of daily sessions (up to 25) to decrease the odds of relapse. The self-reported Beck Depression Inventory II (BDI-II) was used to measure severity of depression. RESULTS Forty-eight (48) patients completed the arTMS course. No serious adverse events occurred, and all patients reported manageable pain levels. Response and remission rates were 35.4% and 27.1% on the BDI-II, respectively, at the end of the tapering course. CONCLUSION If rTMS could be delivered for lower cost at higher volume, while preserving efficacy, safety and tolerability, it could warrant further investigation of this treatment as a first-line intervention in MDD. TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT04376697
Connectivity based Real-Time fMRI Neurofeedback Training in Youth with a History of Major Depressive Disorder

Xiaofu He,Diana Rodriguez Moreno,Zhenghua Hou,Keely Cheslack-Postava,Yanni Jiang,Tong Li,Ronit Kishon,Larry Amsel,George Musa,Zhishun Wang,Christina W. Hoven

DOI: https://doi.org/10.48550/arXiv.2301.11846

2023-01-25

Neurons and Cognition

Abstract:Background: Real-time functional magnetic resonance imaging neurofeedback (rtfMRI-nf) has proven to be a powerful technique to help subjects to gauge and enhance emotional control. Traditionally, rtfMRI-nf has focused on emotional regulation through self-regulation of amygdala. Recently, rtfMRI studies have observed that regulation of a target brain region is accompanied by connectivity changes beyond the target region. Therefore, the aim of present study is to investigate the use of connectivity between amygdala and prefrontal regions as the target of neurofeedback training in healthy individuals and subjects with a life-time history of major depressive disorder (MDD) performing an emotion regulation task. Method: Ten remitted MDD subjects and twelve healthy controls (HC) performed an emotion regulation task in 4 runs of rtfMRI-nf training followed by one transfer run without neurofeedback conducted in a single session. The functional connectivity between amygdala and prefrontal cortex was presented as a feedback bar concurrent with the emotion regulation task. Participants' emotional state was measured by the Positive and Negative Affect Schedule (PANAS) prior to and following the rtfMRI-nf. Psychological assessments were used to determine subjects' history of depression. Results: Participants with a history of MDD showed a trend of decreasing functional connectivity across the four rtfMRI-nf runs, and there was a marginally significant interaction between the MDD history and number of training runs. The HC group showed a significant increase of frontal cortex activation between the second and third neurofeedback runs. Comparing PANAS scores before and after connectivity-based rtfMRI-nf, we observed a significant decrease in negative PANAS score in the whole group overall, and a significant decrease in positive PANAS score in the MDD group alone.
Precision non-implantable neuromodulation therapies: a perspective for the depressed brain

Lucas Borrione,Helena Bellini,Lais Boralli Razza,Ana G Avila,Chris Baeken,Anna-Katharine Brem,Geraldo Busatto,Andre F Carvalho,Adam Chekroud,Zafiris J Daskalakis,Zhi-De Deng,Jonathan Downar,Wagner Gattaz,Colleen Loo,Paulo A Lotufo,Maria da Graça M Martin,Shawn M McClintock,Jacinta O'Shea,Frank Padberg,Ives C Passos,Giovanni A Salum,Marie-Anne Vanderhasselt,Renerio Fraguas,Isabela Benseñor,Leandro Valiengo,Andre R Brunoni

DOI: https://doi.org/10.1590/1516-4446-2019-0741

Abstract:Current first-line treatments for major depressive disorder (MDD) include pharmacotherapy and cognitive-behavioral therapy. However, one-third of depressed patients do not achieve remission after multiple medication trials, and psychotherapy can be costly and time-consuming. Although non-implantable neuromodulation (NIN) techniques such as transcranial magnetic stimulation, transcranial direct current stimulation, electroconvulsive therapy, and magnetic seizure therapy are gaining momentum for treating MDD, the efficacy of non-convulsive techniques is still modest, whereas use of convulsive modalities is limited by their cognitive side effects. In this context, we propose that NIN techniques could benefit from a precision-oriented approach. In this review, we discuss the challenges and opportunities in implementing such a framework, focusing on enhancing NIN effects via a combination of individualized cognitive interventions, using closed-loop approaches, identifying multimodal biomarkers, using computer electric field modeling to guide targeting and quantify dosage, and using machine learning algorithms to integrate data collected at multiple biological levels and identify clinical responders. Though promising, this framework is currently limited, as previous studies have employed small samples and did not sufficiently explore pathophysiological mechanisms associated with NIN response and side effects. Moreover, cost-effectiveness analyses have not been performed. Nevertheless, further advancements in clinical trials of NIN could shift the field toward a more "precision-oriented" practice.
Optomyography-based sensing of facial expression derived arousal and valence in adults with depression

M John Broulidakis,Ivana Kiprijanovska,Liberty Severs,Simon Stankoski,Martin Gjoreski,Ifigeneia Mavridou,Hristijan Gjoreski,Sophia Cox,Daisy Bradwell,James M Stone,Charles Nduka

DOI: https://doi.org/10.3389/fpsyt.2023.1232433

2023-08-08

Abstract:Background: Continuous assessment of affective behaviors could improve the diagnosis, assessment and monitoring of chronic mental health and neurological conditions such as depression. However, there are no technologies well suited to this, limiting potential clinical applications. Aim: To test if we could replicate previous evidence of hypo reactivity to emotional salient material using an entirely new sensing technique called optomyography which is well suited to remote monitoring. Methods: Thirty-eight depressed and 37 controls (≥18, ≤40 years) who met a research diagnosis of depression and an age-matched non-depressed control group. Changes in facial muscle activity over the brow (corrugator supercilli) and cheek (zygomaticus major) were measured whilst volunteers watched videos varying in emotional salience. Results: Across all participants, videos rated as subjectively positive were associated with activation of muscles in the cheek relative to videos rated as neutral or negative. Videos rated as subjectively negative were associated with brow activation relative to videos judged as neutral or positive. Self-reported arousal was associated with a step increase in facial muscle activation across the brow and cheek. Group differences were significantly reduced activation in facial muscles during videos considered subjectively negative or rated as high arousal in depressed volunteers compared with controls. Conclusion: We demonstrate for the first time that it is possible to detect facial expression hypo-reactivity in adults with depression in response to emotional content using glasses-based optomyography sensing. It is hoped these results may encourage the use of optomyography-based sensing to track facial expressions in the real-world, outside of a specialized testing environment.
[Pharmacologic testing of heart function].

H. Bolte

Der Internist

Abstract:
Linking Affect Dynamics and Well-Being: A Novel Methodological Approach for Mental Health

Gloria Simoncini,Francesca Borghesi,Pietro Cipresso

DOI: https://doi.org/10.3390/healthcare12171690

2024-08-27

Health Care

Abstract:Emotions are dynamic processes; their variability relates to psychological well-being and psychopathology. Affective alterations have been linked to mental diseases like depression, although little is known about how similar patterns occur in healthy individuals. This study investigates the psychophysiological correlations of emotional processing in healthy subjects, specifically exploring the relationship between depressive traits, cognitive distortions, and facial electromyographic (f-EMG) responses during affective transitions. A cohort of 44 healthy participants underwent f-EMG recording while viewing emotional images from the International Affective Picture System (IAPS). Self-report measures included the Beck Depression Inventory (BDI) and the Cognitive Distortion Scale (CDS). Higher BDI scores were associated with increased EMG activity in the corrugator muscle during transitions between positive and negative emotional states. Cognitive distortions such as Catastrophizing, All-or-Nothing Thinking, and Minimization showed significant positive correlations with EMG activity, indicating that individuals with higher levels of these distortions experienced greater facial muscle activation during emotional transitions. This study's results indicate that there is a bidirectional correlation between depressed features and cognitive distortions and alterations in facial emotional processing, even in healthy subjects. Facial EMG in the context of dynamic affective transitions has the potential to be used as a non-invasive method for detecting abnormal emotional reactions at an early stage. This might help in identifying individuals who are at risk of developing depression and guide therapies to prevent its advancement.

health care sciences & services,health policy & services

Lead discovery: Tailoring nuclear receptor activation

Physiologically informed neuromodulation

Precoding and Power Allocation for Full-Duplex MIMO Relays

Reversible and Noninvasive Modulation of a Historical Surgical Target for Depression with Low Intensity Focused Ultrasound

Brain-Computer Interface Based Neuromodulation on Treatment of Depression

Non-Invasive Electric and Magnetic Brain Stimulation for the Treatment of Fibromyalgia

Zygomaticus activation through facial neuromuscular electric stimulation (fNMES) induces happiness perception in ambiguous facial expressions and affects neural correlates of face processing

Brief Myofascial Intervention Modulates Visual Event-Related Potential Response to Emotional Photographic Contents: A Pilot Study

Epidemiological aspects of vector, parasite, and domestic reservoir in areas of recent transmission and no reported human cases of visceral leishmaniasis in Brazil.

Emotion self-regulation training in major depressive disorder using simultaneous real-time fMRI and EEG neurofeedback

Neural responses to facial emotions and subsequent clinical outcomes in difficult-to-treat depression

Facing emotions: real-time fMRI-based neurofeedback using dynamic emotional faces to modulate amygdala activity

Brain stimulation over the left DLPFC enhances motivation for effortful rewards in patients with major depressive disorder

Thermo-mechanical analysis of MEMS pressure sensor die-attach for high temperature applications

Major depressive disorder associated alterations in the effective connectivity of the face processing network: a systematic review

Evaluation of a Novel Therapeutic Repetitive Transcranial Magnetic Stimulation Technique Optimized for Increased Accessibility in Major Depression

Connectivity based Real-Time fMRI Neurofeedback Training in Youth with a History of Major Depressive Disorder

Precision non-implantable neuromodulation therapies: a perspective for the depressed brain

Optomyography-based sensing of facial expression derived arousal and valence in adults with depression

[Pharmacologic testing of heart function].

Linking Affect Dynamics and Well-Being: A Novel Methodological Approach for Mental Health